Lumpipulse G CA19-9-N— 510(k) K191973

Name: FDA 510(k) clearance K191973
Creator: U.S. Food and Drug Administration
Published: 2019-10-22

Substantially Equivalent

Fujirebio Dianostics, Inc.

FDA 510(k) clearance K191973 for Lumpipulse G CA19-9-N, Substantially Equivalent on 2019-10-22. Applicant: Fujirebio Dianostics, Inc.. Device class: 2.

Clearance details

Applicant: Fujirebio Dianostics, Inc.
Product code: Code NIG
Device class: Class 2
Regulation: 21 CFR 866.6010
Advisory panel: Immunology
Date received: 2019-07-24
Decision date: 2019-10-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Malvern, PA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code NIG

view all

K253528 — Atellica IM CA 19-9 II2026-08-10
K231525 — VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack2023-08-09
K200997 — Lumipulse G CA19-9-N2020-05-14
K100375 — DIMENSION VISTA LOCI CA 19-9 FLEX REAGENT CARTRIDGE, AND DIMENSION LOCI7 CALIBRATOR WITH MODEL(S) K6457, AND KC6042011-04-06
K052889 — VITROS CA 19-92005-12-20

Adverse events under product code NIG

product code NIG

Malfunction: 618
Total: 618

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.